Literature DB >> 25893454

Fecal microbiota transplant for recurrent Clostridium difficile infection after peripheral autologous stem cell transplant for diffuse large B-cell lymphoma.

C Mittal1, N Miller1, A Meighani1, B R Hart1, A John1, M Ramesh1.   

Abstract

Entities:  

Mesh：

Year:  2015        PMID： 25893454     DOI： 10.1038/bmt.2015.85

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN： 0268-3369            Impact factor:   5.483


× No keyword cloud information.
  6 in total

1.  CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma.

Authors:  Bertrand Coiffier; Eric Lepage; Josette Briere; Raoul Herbrecht; Hervé Tilly; Reda Bouabdallah; Pierre Morel; Eric Van Den Neste; Gilles Salles; Philippe Gaulard; Felix Reyes; Pierre Lederlin; Christian Gisselbrecht
Journal:  N Engl J Med       Date:  2002-01-24       Impact factor: 91.245

2.  Fecal microbiota transplant after hematopoietic SCT: report of a successful case.

Authors:  C G de Castro; A J Ganc; R L Ganc; M S Petrolli; N Hamerschlack
Journal:  Bone Marrow Transplant       Date:  2014-09-29       Impact factor: 5.483

Review 3.  Fecal microbiota transplantation for the treatment of Clostridium difficile infection: a systematic review.

Authors:  Giovanni Cammarota; Gianluca Ianiro; Antonio Gasbarrini
Journal:  J Clin Gastroenterol       Date:  2014-09       Impact factor: 3.062

4.  Duodenal infusion of donor feces for recurrent Clostridium difficile.

Authors:  Els van Nood; Anne Vrieze; Max Nieuwdorp; Susana Fuentes; Erwin G Zoetendal; Willem M de Vos; Caroline E Visser; Ed J Kuijper; Joep F W M Bartelsman; Jan G P Tijssen; Peter Speelman; Marcel G W Dijkgraaf; Josbert J Keller
Journal:  N Engl J Med       Date:  2013-01-16       Impact factor: 91.245

5.  Fecal microbiota transplantation for fulminant Clostridium difficile infection in an allogeneic stem cell transplant patient.

Authors:  K Neemann; D D Eichele; P W Smith; R Bociek; M Akhtari; A Freifeld
Journal:  Transpl Infect Dis       Date:  2012-11-02       Impact factor: 2.228

Review 6.  Clinical efficacy of fidaxomicin compared with vancomycin and metronidazole in Clostridium difficile infections: a meta-analysis and indirect treatment comparison.

Authors:  Oliver A Cornely; Dilip Nathwani; Cristina Ivanescu; Olatunji Odufowora-Sita; Peny Retsa; Isaac A O Odeyemi
Journal:  J Antimicrob Chemother       Date:  2014-07-28       Impact factor: 5.790
  6 in total
  12 in total

Review 1.  Microbiota Manipulation With Prebiotics and Probiotics in Patients Undergoing Stem Cell Transplantation.

Authors:  Tessa M Andermann; Andrew Rezvani; Ami S Bhatt
Journal:  Curr Hematol Malig Rep       Date:  2016-02       Impact factor: 3.952

Review 2.  Antibiotics, gut microbiota, environment in early life and type 1 diabetes.

Authors:  Youjia Hu; F Susan Wong; Li Wen
Journal:  Pharmacol Res       Date:  2017-02-07       Impact factor: 7.658

3.  Third-party fecal microbiota transplantation following allo-HCT reconstitutes microbiome diversity.

Authors:  Zachariah DeFilipp; Jonathan U Peled; Shuli Li; Jasmin Mahabamunuge; Zeina Dagher; Ann E Slingerland; Candice Del Rio; Betsy Valles; Maria E Kempner; Melissa Smith; Jami Brown; Bimalangshu R Dey; Areej El-Jawahri; Steven L McAfee; Thomas R Spitzer; Karen K Ballen; Anthony D Sung; Tara E Dalton; Julia A Messina; Katja Dettmer; Gerhard Liebisch; Peter Oefner; Ying Taur; Eric G Pamer; Ernst Holler; Michael K Mansour; Marcel R M van den Brink; Elizabeth Hohmann; Robert R Jenq; Yi-Bin Chen
Journal:  Blood Adv       Date:  2018-04-10

Review 4.  Clostridioides difficile Infection in the Stem Cell Transplant and Hematologic Malignancy Population.

Authors:  Elizabeth Ann Misch; Nasia Safdar
Journal:  Infect Dis Clin North Am       Date:  2019-06       Impact factor: 5.982

Review 5.  The gut microbiota in transplant patients.

Authors:  Pearlie P Chong; Andrew Y Koh
Journal:  Blood Rev       Date:  2019-08-29       Impact factor: 8.250

Review 6.  The Microbiome and Hematopoietic Cell Transplantation: Past, Present, and Future.

Authors:  Tessa M Andermann; Jonathan U Peled; Christine Ho; Pavan Reddy; Marcie Riches; Rainer Storb; Takanori Teshima; Marcel R M van den Brink; Amin Alousi; Sophia Balderman; Patrizia Chiusolo; William B Clark; Ernst Holler; Alan Howard; Leslie S Kean; Andrew Y Koh; Philip L McCarthy; John M McCarty; Mohamad Mohty; Ryotaro Nakamura; Katy Rezvani; Brahm H Segal; Bronwen E Shaw; Elizabeth J Shpall; Anthony D Sung; Daniela Weber; Jennifer Whangbo; John R Wingard; William A Wood; Miguel-Angel Perales; Robert R Jenq; Ami S Bhatt
Journal:  Biol Blood Marrow Transplant       Date:  2018-02-19       Impact factor: 5.742

7.  Long-term taxonomic and functional divergence from donor bacterial strains following fecal microbiota transplantation in immunocompromised patients.

Authors:  Eli L Moss; Shannon B Falconer; Ekaterina Tkachenko; Mingjie Wang; Hannah Systrom; Jasmin Mahabamunuge; David A Relman; Elizabeth L Hohmann; Ami S Bhatt
Journal:  PLoS One       Date:  2017-08-21       Impact factor: 3.240

Review 8.  Insights into the role of intestinal microbiota in hematopoietic stem-cell transplantation.

Authors:  Daniele Zama; Gianluca Bossù; Davide Leardini; Edoardo Muratore; Elena Biagi; Arcangelo Prete; Andrea Pession; Riccardo Masetti
Journal:  Ther Adv Hematol       Date:  2020-01-20

9.  A Systematic Review of the Efficacy and Safety of Fecal Microbiota Transplant for Clostridium difficile Infection in Immunocompromised Patients.

Authors:  Oluwaseun Shogbesan; Dilli Ram Poudel; Samjeris Victor; Asad Jehangir; Opeyemi Fadahunsi; Gbenga Shogbesan; Anthony Donato
Journal:  Can J Gastroenterol Hepatol       Date:  2018-09-02

Review 10.  Fecal microbiota transplantation in cancer management: Current status and perspectives.

Authors:  Danfeng Chen; Jingyi Wu; Duochen Jin; Bangmao Wang; Hailong Cao
Journal:  Int J Cancer       Date:  2018-12-30       Impact factor: 7.396
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.